Search Results - "Callanan MB"

Diverse roles of YTHDC1 in chromatin and blood cancers.

Authors: Pernon B Benchikh Y Fournier C et al.

Source: Frontiers in genetics [Front Genet] 2026 May 08; Vol. 17, pp. 1773468. Date of Electronic Publication: 2026 May 08 (Print Publication: 2026).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101560621 Publication Model: eCollection Cited Medium: Print ISSN: 1664-8021 (Print) Linking ISSN: 16648021 NLM ISO Abbreviation: Front Genet Subsets: PubMed not MEDLINE

The MCL elderly III trial protocol: an international, randomized, open-label phase II trial to investigate the combinations of venetoclax, ibrutinib and rituximab or bendamustine, ibrutinib and rituximab in patients with treatment naive mantle cell lymphoma not eligible for dose-intensive treatment

Authors: Herold, Stephanie Schmidt, Christian Visco, Carlo et al.

Source: BMC Cancer. 8/25/2025, Vol. 25 Issue 1, p1-9. 9p.

Pharmacological inhibition of bromodomain and extra-terminal proteins induces an NRF-2-mediated antiviral state that is subverted by SARS-CoV-2 infection.

Authors: Mhlekude, Baxolele Postmus, Dylan Stenzel, Saskia et al.

Source: PLoS Pathogens. 9/25/2023, Vol. 19 Issue 9, p1-37. 37p.

BET inhibition revealed varying MYC dependency mechanisms independent of gene alterations in aggressive B-cell lymphomas.

Authors: Delrieu, Loris Hamaidia, Sieme Montaut, Emilie et al.

Source: Clinical Epigenetics. 12/19/2024, Vol. 16 Issue 1, p1-18. 18p.

Bromodomain-containing 4 is a Positive Regulator of the Inflammatory Cytokine Response in the Gut.

Authors: Franzè, Eleonora Laudisi, Federica Maresca, Claudia et al.

Source: Journal of Crohn's & Colitis. Dec2024, Vol. 18 Issue 12, p1995-2009. 15p.

Optimized fungal chitosan-based pegasparaginase immobilization for intravenous delivery to enhance treatment of acute lymphoblastic leukaemia.

Authors: Kathpalia, Karishma Vivek Verma, Awadhesh Kumar Mohan, Anand et al.

Source: Future Journal of Pharmaceutical Sciences. 10/6/2025, Vol. 11 Issue 1, p1-32. 32p.

Mcl-1 is an important target protein for kaempferol from persimmon leaves in sensitizing ABT-199 to induce apoptosis in hepatoma cancer cells.

Authors: Chen L Jiang XD Liu XP et al.

Source: Medical oncology (Northwood, London, England) [Med Oncol] 2025 Apr 01; Vol. 42 (5), pp. 146. Date of Electronic Publication: 2025 Apr 01.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE

Radio-sensitization of mutated KRAS G12C non-small cell lung cancer with KRAS G12C tyrosine kinase inhibitor and carbon ions irradiation.

Authors: Césaire M Lecrosnier K Montanari J et al.

Source: Molecular and cellular biochemistry [Mol Cell Biochem] 2026 Jul 31. Date of Electronic Publication: 2026 Jul 31.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: Netherlands NLM ID: 0364456 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-4919 (Electronic) Linking ISSN: 03008177 NLM ISO Abbreviation: Mol Cell Biochem Subsets: MEDLINE

Approfondir la compréhension biologique du lymphome à cellules du manteau pour favoriser l'innovation thérapeutique.

Authors: Frankowski, Enzo Hervouet, Louise Papin, Antonin et al.

Source: Hematologie. jul/aug2025, Vol. 31 Issue 4, p287-303. 17p.

BET Family Protein BRD4: An Emerging Actor in NFκB Signaling in Inflammation and Cancer.

Authors: Hajmirza A Emadali A Gauthier A et al.

Source: Biomedicines [Biomedicines] 2018 Feb 06; Vol. 6 (1). Date of Electronic Publication: 2018 Feb 06.

Publication Type: Journal Article; Review

Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE

MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells.

Authors: Limagne E Nuttin L Thibaudin M et al.

Source: Cancer cell [Cancer Cell] 2022 Feb 14; Vol. 40 (2), pp. 136-152.e12. Date of Electronic Publication: 2022 Jan 19.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma.

Authors: Thieme, Elana Bruss, Nur Sun, Duanchen et al.

Source: Molecular Cancer. 3/30/2023, Vol. 22 Issue 1, p1-17. 17p.

Continuous R-DA-EDOCH alternated with high-dose Ara-C induces deep remission and overcomes high-risk factors in young patients with newly diagnosed mantle cell lymphoma.

Authors: Yi Wang Yuting Yan Dandan Shan et al.

Source: Cancer Biology & Medicine. Feb2025, Vol. 22 Issue 2, p177-189. 13p.

Non-genetic stratification reveals epigenetic heterogeneity and identifies vulnerabilities of glycolysis addiction in lung adenocarcinoma subtype.

Authors: Song, Xuming Zhang, Te Ding, Hanlin et al.

Source: Oncogenesis. 10/10/2022, Vol. 11 Issue 1, p1-12. 12p.

Fc gamma receptors: Their evolution, genomic architecture, genetic variation, and impact on human disease.

Authors: Frampton, Sarah Smith, Rosanna Ferson, Lili et al.

Source: Immunological Reviews. Nov2024, Vol. 328 Issue 1, p65-97. 33p.

TINCR inhibits the proliferation and invasion of laryngeal squamous cell carcinoma by regulating miR-210/BTG2.

Authors: He, Guoqing Pang, Rui Han, Jihua et al.

Source: BMC Cancer. 6/29/2021, Vol. 21 Issue 1, p1-16. 16p.

Disruption of super-enhancer-driven tumor suppressor gene RCAN1.4 expression promotes the malignancy of breast carcinoma.

Authors: Deng, Rong Huang, Jun-Hao Wang, Yan et al.

Source: Molecular Cancer. 8/8/2020, Vol. 19 Issue 1, p1-19. 19p. 1 Color Photograph, 1 Diagram, 4 Graphs.

Dual HDAC/BRD4 inhibitors against cancer.

Authors: Omidkhah, Negar Hadizadeh, Farzin Ghodsi, Razieh

Source: Medicinal Chemistry Research. Oct2021, Vol. 30 Issue 10, p1822-1836. 15p.

FASTKD1 as a diagnostic and prognostic biomarker for STAD: Insights into m6A modification and immune infiltration.

Authors: Yang, Yi Gao, Yan Liu, Xu-Sheng et al.

Source: Experimental & Therapeutic Medicine. Aug2024, Vol. 28 Issue 2, pN.PAG-N.PAG. 1p.

Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.

Authors: Emadali A Rousseaux S Bruder-Costa J et al.

Source: EMBO molecular medicine [EMBO Mol Med] 2013 Aug; Vol. 5 (8), pp. 1180-95. Date of Electronic Publication: 2013 Jul 04.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE